Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Risk factors of bone mineral metabolic disorders.

PMID: 31862224
Journal: Seminars in Fetal & Neonatal Medicine
Year: 2020
Reference: Semin Fetal Neonatal Med. 2020 Feb;25(1):101068. doi: 10.1016/j.siny.2019.101068. Epub 2019 Dec 2.
Impact factor: 3.54
Publication type: Paper in international publication
Authors: Montaner Ramon, Alicia et al.
DOI: 10.1016/j.siny.2019.101068

Risk factors of bone mineral metabolic disorders.

PMID: 31862224
Journal: Seminars in Fetal & Neonatal Medicine
Year: 2020
Reference: Semin Fetal Neonatal Med. 2020 Feb;25(1):101068. doi: 10.1016/j.siny.2019.101068. Epub 2019 Dec 2.
Impact factor:
Publication type: Paper in international publication
Authors: Montaner Ramon, Alicia et al.
DOI: 10.1016/j.siny.2019.101068

Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort >/=65 Years of Age.

PMID: 33149596
Journal: Vascular health and risk management
Year: 2020
Reference: Vasc Health Risk Manag. 2020 Oct 28;16:445-454. doi: 10.2147/VHRM.S276477. eCollection 2020.
Impact factor: 0
Publication type: Paper in international publication
Authors: Clua-Espuny, Jose-Luis, Muria-Subirats, Eulalia, Clua-Queralt, Josep, Pala, Elena, Lechuga-Duran, Inigo, Gentille-Lorente, Delicia, Bustamante, Alejandro, Munoz, Miguel Angel, Montaner, Joan, Lorman-Carbo, Blanca et al.
DOI: 10.2147/VHRM.S276477

Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort >/=65 Years of Age.

PMID: 33149596
Journal: Vascular health and risk management
Year: 2020
Reference: Vasc Health Risk Manag. 2020 Oct 28;16:445-454. doi: 10.2147/VHRM.S276477. eCollection 2020.
Impact factor:
Publication type: Paper in international publication
Authors: Ballesta-Ors, Juan; Bustamante, Alejandro; Clua-Espuny, Jose-Luis; Clua-Queralt, Josep; Gentille-Lorente, Delicia; Lechuga-Duran, Inigo; Lorman-Carbo, Blanca; Montaner, Joan; Munoz, Miguel Angel; Muria-Subirats, Eulalia et al.
DOI: 10.2147/VHRM.S276477

Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome.

PMID: 32784934
Journal: Cancers
Year: 2020
Reference: Cancers (Basel). 2020 Aug 9;12(8). pii: cancers12082225. doi: 10.3390/cancers12082225.
Impact factor: 6.126
Publication type: Paper in international publication
Authors: Bujanda, Luis, Lopez-Fernandez, Adria, Alvarez-Urturi, Cristina, Lopez, Maria Jesus, Alenda, Cristina, Zapater, Pedro, Lacueva, Francisco Javier, Balaguer, Francesc, Soto, Jose-Luis, Murcia, Oscar et al.
DOI: 10.3390/cancers12082225

Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome.

PMID: 32784934
Journal: Cancers
Year: 2020
Reference: Cancers (Basel). 2020 Aug 9;12(8). pii: cancers12082225. doi: 10.3390/cancers12082225.
Impact factor:
Publication type: Paper in international publication
Authors: Alenda, Cristina; Alustiza, Miren; Alvarez-Urturi, Cristina; Balaguer, Francesc; Bujanda, Luis; Carrillo-Palau, Marta; Castells, Antoni; Castillejo, Adela; Cubiella, Joaquin; Garau, Catalina et al.
DOI: 10.3390/cancers12082225

Risk of infection associated with new therapies for the treatment of lymphoproliferative syndromes.

PMID: 31771856
Journal: MEDICINA CLINICA
Year: 2020
Reference: Med Clin (Barc). 2020 Feb 14;154(3):101-107. doi: 10.1016/j.medcli.2019.07.026. Epub 2019 Nov 23.
Impact factor: 1.635
Publication type: Review in national publication
Authors: Ruiz-Camps, Isabel, Aguilar-Company, Juan, Los-Arcos, Ibai et al.
DOI: 10.1016/j.medcli.2019.07.026

Risk of infection associated with new therapies for the treatment of lymphoproliferative syndromes.

PMID: 31771856
Journal: MEDICINA CLINICA
Year: 2020
Reference: Med Clin (Barc). 2020 Feb 14;154(3):101-107. doi: 10.1016/j.medcli.2019.07.026. Epub 2019 Nov 23.
Impact factor:
Publication type: Review in national publication
Authors: Aguilar-Company, Juan; Los-Arcos, Ibai; Ruiz-Camps, Isabel et al.
DOI: 10.1016/j.medcli.2019.07.026

Risk of Secondary Infection Waves of COVID-19 in an Insular Region: The Case of the Balearic Islands, Spain

PMID: NOPMID0081
Journal: Frontiers in Medicine
Year: 2020
Reference: Frontiers in Medicine. 2020;7:905. doi: 10.3389/fmed.2020.563455
Impact factor: 3.9
Publication type: Paper in international publication
Authors: , , , , et al.
DOI: 10.3389/fmed.2020.563455

Risk of Secondary Infection Waves of COVID-19 in an Insular Region: The Case of the Balearic Islands, Spain.

PMID: 33425932
Journal: Frontiers in Medicine
Year: 2020
Reference: Front Med (Lausanne). 2020 Dec 15;7:563455. doi: 10.3389/fmed.2020.563455. eCollection 2020.
Impact factor: 3.9
Publication type: Paper in international publication
Authors: Eguiluz, Victor M, Fernandez-Gracia, Juan, Rodriguez, Jorge P, Pericas, Juan M, Melian, Carlos et al.
DOI: 10.3389/fmed.2020.563455

Risk of Secondary Infection Waves of COVID-19 in an Insular Region: The Case of the Balearic Islands, Spain

PMID: NOPMID0081
Journal: Frontiers in Medicine
Year: 2020
Reference: Frontiers in Medicine. 2020;7:905. doi: 10.3389/fmed.2020.563455
Impact factor:
Publication type: Paper in international publication
Authors: ; ; ; ; et al.
DOI: 10.3389/fmed.2020.563455

Risk of Secondary Infection Waves of COVID-19 in an Insular Region: The Case of the Balearic Islands, Spain.

PMID: 33425932
Journal: Frontiers in Medicine
Year: 2020
Reference: Front Med (Lausanne). 2020 Dec 15;7:563455. doi: 10.3389/fmed.2020.563455. eCollection 2020.
Impact factor:
Publication type: Paper in international publication
Authors: Eguiluz, Victor M; Fernandez-Gracia, Juan; Melian, Carlos; Pericas, Juan M; Rodriguez, Jorge P et al.
DOI: 10.3389/fmed.2020.563455

Risk-adjusted early invasive strategy in patients with non-ST-segment elevation acute coronary syndrome in Intensive Cardiac Care Units.

PMID: 31362838
Journal: Medicina Intensiva
Year: 2020
Reference: Med Intensiva. 2020 Nov;44(8):475-484. doi: 10.1016/j.medin.2019.06.006. Epub 2019 Jul 27.
Impact factor: 2.363
Publication type: Paper in national publication
Authors: Llao, I, Gomez-Hospital, J A, Aboal, J, Garcia, C, Montero, S, Sambola, A, Ortiz, J, Tomas, C, Bonet, G, Vinas, D et al.
DOI: 10.1016/j.medin.2019.06.006

Risk-adjusted early invasive strategy in patients with non-ST-segment elevation acute coronary syndrome in Intensive Cardiac Care Units.

PMID: 31362838
Journal: Medicina Intensiva
Year: 2020
Reference: Med Intensiva. 2020 Nov;44(8):475-484. doi: 10.1016/j.medin.2019.06.006. Epub 2019 Jul 27.
Impact factor:
Publication type: Paper in national publication
Authors: Aboal, J; Andrea, R; Ariza-Sole, A; Bonet, G; Cantalapiedra, J; Cequier, A; Garcia, C; Gomez-Hospital, J A; Gual, M; Hernandez, I et al.
DOI: 10.1016/j.medin.2019.06.006

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.

PMID: 31699660
Journal: Lancet Haematology
Year: 2020
Reference: Lancet Haematol. 2020 Jan;7(1):e18-e27. doi: 10.1016/S2352-3026(19)30219-4. Epub 2019 Nov 5.
Impact factor: 10.406
Publication type: Paper in international publication
Authors: Petrilli, Antonio, Male, Christoph, Lensing, Anthonie W A, Palumbo, Joseph S, Kumar, Riten, Majumder, Madhurima, Smith, William T, Heubach, Jurgen F, Berkowitz, Scott D, Thelen, Kirstin et al.
DOI: 10.1016/S2352-3026(19)30219-4

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.

PMID: 31699660
Journal: Lancet Haematology
Year: 2020
Reference: Lancet Haematol. 2020 Jan;7(1):e18-e27. doi: 10.1016/S2352-3026(19)30219-4. Epub 2019 Nov 5.
Impact factor:
Publication type: Paper in international publication
Authors: Abbattista, Maria; Ahuja, Sanjay; Albisetti-Pedroni, Manuela; Amedro, Pascal; Amedro, Pascal; Anjos, Rui; Antmen, Ali; Aramburo, Angela; Artoni, Andrea; Azeka, Estela et al.
DOI: 10.1016/S2352-3026(19)30219-4

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr Phase 3 dose-exposure-response evaluation.

PMID: 32246743
Journal: JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Year: 2020
Reference: J Thromb Haemost. 2020 Jul;18(7):1672-1685. doi: 10.1111/jth.14813. Epub 2020 Jun 4.
Impact factor: 4.157
Publication type: Paper in international publication
Authors: Young, Guy, Lensing, Anthonie W A, Monagle, Paul, Male, Christoph, Thelen, Kirstin, Willmann, Stefan, Palumbo, Joseph S, Nurmeev, Ildar, Grangl, Gernot, Van Damme, An et al.
DOI: 10.1111/jth.14813

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr Phase 3 dose-exposure-response evaluation.

PMID: 32246743
Journal: JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Year: 2020
Reference: J Thromb Haemost. 2020 Jul;18(7):1672-1685. doi: 10.1111/jth.14813. Epub 2020 Jun 4.
Impact factor:
Publication type: Paper in international publication
Authors: Abbattista, Maria; Ahuja, Sanjay; Amedro, Pascal; Amedro, Pascal; Anjos, Rui; Antmen, Ali; Aramburo, Angela; Artoni, Andrea; Azeka, Estela; Baird, Susan et al.
DOI: 10.1111/jth.14813

Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome.

PMID: 32926827
Journal: ANNALS OF INTERNAL MEDICINE
Year: 2020
Reference: Ann Intern Med. 2020 Sep 15;173(6):505-506. doi: 10.7326/L20-0054.
Impact factor: 21.317
Publication type: Letter or abstract
Authors: Cortes-Hernandez, Josefina et al.
DOI: 10.7326/L20-0054

Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome.

PMID: 32926827
Journal: ANNALS OF INTERNAL MEDICINE
Year: 2020
Reference: Ann Intern Med. 2020 Sep 15;173(6):505-506. doi: 10.7326/L20-0054.
Impact factor:
Publication type: Letter or abstract
Authors: Cortes-Hernandez, Josefina et al.
DOI: 10.7326/L20-0054

[Robotic and laparosocpic urological surgery during COVID-19 pandemia.]

PMID: 32538818
Journal: ARCHIVOS ESPANOLES DE UROLOGIA
Year: 2020
Reference: Arch Esp Urol. 2020 Jun;73(5):463-470.
Impact factor: 0.395
Publication type: Review in national publication
Authors: Carracedo, David, Alcaraz, Antonio, Allona, Antonio, Gutierrez, Jose Luis, Lopez-Fando, Luis, Medina, Rafael Antonio, Moncada, Ignacio, Moreno, Jesus, Palou, Joan, Pereira, Jose Gregorio et al.
DOI:

[Robotic and laparosocpic urological surgery during COVID-19 pandemia.]

PMID: 32538818
Journal: ARCHIVOS ESPANOLES DE UROLOGIA
Year: 2020
Reference: Arch Esp Urol. 2020 Jun;73(5):463-470.
Impact factor:
Publication type: Review in national publication
Authors: Alcaraz, Antonio; Allona, Antonio; Carracedo, David; Gutierrez, Jose Luis; Lopez-Fando, Luis; Medina, Rafael Antonio; Moncada, Ignacio; Moreno, Jesus; Palou, Joan; Pereira, Jose Gregorio et al.
DOI:

Robotic excision of full-thickness diaphragmatic endometriosis.

PMID: 31487553
Journal: Journal of Minimally Invasive Gynecology
Year: 2020
Reference: J Minim Invasive Gynecol. 2020 May - Jun;27(4):815. doi: 10.1016/j.jmig.2019.08.025. Epub 2019 Sep 2.
Impact factor: 3.107
Publication type: Paper in international publication
Authors: Delara, Ritchie Mae, Suarez-Salvador, Elena, Magrina, Javier, Magtibay, Paul et al.
DOI: 10.1016/j.jmig.2019.08.025

Robotic excision of full-thickness diaphragmatic endometriosis.

PMID: 31487553
Journal: Journal of Minimally Invasive Gynecology
Year: 2020
Reference: J Minim Invasive Gynecol. 2020 May - Jun;27(4):815. doi: 10.1016/j.jmig.2019.08.025. Epub 2019 Sep 2.
Impact factor:
Publication type: Paper in international publication
Authors: Delara, Ritchie Mae; Magrina, Javier; Magtibay, Paul; Suarez-Salvador, Elena et al.
DOI: 10.1016/j.jmig.2019.08.025

Publications

Publications searcher

Risk factors of bone mineral metabolic disorders.

Risk factors of bone mineral metabolic disorders.

Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort >/=65 Years of Age.

Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort >/=65 Years of Age.

Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome.

Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome.

Risk of infection associated with new therapies for the treatment of lymphoproliferative syndromes.

Risk of infection associated with new therapies for the treatment of lymphoproliferative syndromes.

Risk of Secondary Infection Waves of COVID-19 in an Insular Region: The Case of the Balearic Islands, Spain

Risk of Secondary Infection Waves of COVID-19 in an Insular Region: The Case of the Balearic Islands, Spain.

Risk of Secondary Infection Waves of COVID-19 in an Insular Region: The Case of the Balearic Islands, Spain

Risk of Secondary Infection Waves of COVID-19 in an Insular Region: The Case of the Balearic Islands, Spain.

Risk-adjusted early invasive strategy in patients with non-ST-segment elevation acute coronary syndrome in Intensive Cardiac Care Units.

Risk-adjusted early invasive strategy in patients with non-ST-segment elevation acute coronary syndrome in Intensive Cardiac Care Units.

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr Phase 3 dose-exposure-response evaluation.

Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr Phase 3 dose-exposure-response evaluation.

Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome.

Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome.

[Robotic and laparosocpic urological surgery during COVID-19 pandemia.]

[Robotic and laparosocpic urological surgery during COVID-19 pandemia.]

Robotic excision of full-thickness diaphragmatic endometriosis.

Robotic excision of full-thickness diaphragmatic endometriosis.

Patronage:

Collaborating:

Accreditations: